Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...
The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...
REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...
Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...
Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma ...
The jump from training to independent practice is a uniquely personal experience. For some, it feels like a natural next step ...
The tension between STAAR and Broadwood Partners continues as both have issued further statements for and against the ...
Privosegtor (also known as OCS-05) is a “first-in-class peptoid small molecule” for neuroprotective therapy for acute optic ...
Treatment-Resistant AMD and Diabetic Macular EdemaWith High-Dose Aflibercept Summary. This presentation examines the ...
Study finds retinal progenitor cell injections improve outcomes in rat model of diabetic retinopathy
Intravitreal RPCs showed positive effects on electroretinography, optomotor response, and contrast sensitivity in a rat model ...
The YOURS Committee supports young retina specialists with educational initiatives, professional development, and networking ...
The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing aflibercept (EYLEA) for the treatment of neovascular (wet) age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback